JAK2 and osteosarcoma: We treated osteosarcoma cell lines with anti-tumor agent and some specific inhibitors including ERK inhibitor, HIF1-α inhibitor, JAK2 inhibitor, LY294002, and others but we were unable to inhibit EGR1 expression effectively.